期刊文献+

动态增强MRI在前列腺癌中的应用及进展 被引量:3

原文传递
导出
摘要 前列腺疾病是男性的常见病和多发病,近年来前列腺癌(prostate cancer)在我国的发病率逐年上升[1],已成为危害我国老年男性生命健康的重要疾病.随着MR应用研究和计算机后处理技术的不断发展,MR功能成像在前列腺癌的诊断及治疗后疗效的评估中开辟了新的领域,包括MR扩散加权成像(diffusion weighted imaging,DWI)、动态对比增强MRI(dynamic contrast-enhanced MRI,DCE-MRI)、MR波谱成像(MR spectroscopy,MRS)、血氧水平依赖性成像(blood oxygen level dependent imaging,BOLD)和MR灌注加权成像(perfusion weighted imaging,PWI)等技术.
作者 李鹏 陈志强
出处 《中华临床医师杂志(电子版)》 CAS 2012年第10期164-166,共3页 Chinese Journal of Clinicians(Electronic Edition)
基金 宁夏自然科学基金(NZ09110) 宁夏医科大学面上项目(XM200840)
  • 相关文献

参考文献26

  • 1孙颖浩.我国前列腺癌的研究现状[J].中华泌尿外科杂志,2004,25(2):77-80. 被引量:354
  • 2Bonekamp D, Maeura KJ. Dynamic contrast-enhanced magnetic res- onance imaging in the evaluation of the prostate. Top Magn Reson Ima- ging, 2008,19 : 273 -284.
  • 3Schlemmer HP, Merkle J, Grobholze R, et al. Can pre-operative con- trast-enhanced dynamic MR imaging for prostate cancer predict mi- crovessel density in prostatectomy specimens? Eur Radiol,2004,14: 309-317.
  • 4O'Connor JP, Jackson A, Parker GJ, et al. DCE-MRI biomarkers in the clinical evaluation of antiangiogenic and vascular disrupting agents. Br J Cancer,2007,96 : 189-195.
  • 5Offersen BV, Bone M, Overgaard J. Quantification of angiogenesis as a prognostic marker in human carcinomas: a critical evaluation of his- topathologieal methods for estimation of vascular density. Eur J Canc- er,2003,39:881-890.
  • 6Ren J, Huan Y, Wang H, et al. Dynamic contrast-enhanced MRI of be- nign prostatic hyperplasia and prostatic carcinoma:correlation with an- giogenesis. Clin Radiol,2008,63 : 153-159.
  • 7Checkley D, Tessier JJ, Kendrew J, et al. Usd of dynamic contrast-en- hanced MRI to evaluate acute treatment with ZD6474, a VEGF signa- ling inhibitor, in PC-3 prostate tumours. Br J Cancer, 2003, 89: 1889-1895.
  • 8Noworolski SM, Henry RG, Vigneron DB, et al. Dynamic contrast-en- hanced MRI in normal and abnormal prostate tissues as defined by bi- opsy,MRI,and 3D MRSI. Magn Reson Med,2005,53:249-255.
  • 9Hara N, Okuizumi M, Koike H, et al. Dynamic contrastenhanced mag- netic resonance imaging(DCE-MRI) is a useful modality for the pre- cise detection and staging of early prostate cancer. Prostate, 2005,62: 140-147.
  • 10Kozlowski P, Chang SD, Jones EC, et al. Combined diffusion-weighted and dynamic contrast-enhanced MRI for prostate cancer diagnosis cor- relation with biopsy and histopathology. J Magn Reson Imaging,2006, 24 : 108-113.

二级参考文献23

  • 1王刚,周利群,那彦群.良性前列腺增生术后前列腺偶发癌10年回顾性分析[J].中华泌尿外科杂志,2005,26(2):117-120. 被引量:38
  • 2宋刚,周利群,何志嵩,李宁忱,李鸣,郝金瑞,潘柏年,那彦群.前列腺特异抗原联合分级对前列腺癌患者分期的预测[J].中华外科杂志,2006,44(6):376-378. 被引量:9
  • 32004年上海市市区恶性肿瘤发病率[J].肿瘤,2007,27(7):594-594. 被引量:23
  • 4Aus G,Abbou CC,Bolla M,et al.EAU guidelines on prostate cancer.Eur Urol,2005,48(4):546-551.
  • 5Devlin HL,Mudryj M.Progression of prostate cancer:multiple pathways to androgen independence.Cancer Lett,2009,274 (2):177-186.
  • 6So A,Gleave M,Hurtado-Col A,et al.Mechanisms of the development of androgen independence in prostate cancer.World J Urol,2005,23(1):1-9.
  • 7Cho D,Di Blasio CJ,Rhee AC,et al.Prognostic factors for survival in patients with hormone-refractory prostate cancer(HRPC) after initial androgen deprivation therapy (ADT).Urol Oncol,2003,21(4):282-291.
  • 8Bamias A,Bozas G,Antoniou N,et al.Prognostic and predictive factors in patients with androgen-independent prostate cancer treated with docetaxel and estramustine:a single institution experience.Eur Urol,2008,53 (2):323-331.
  • 9Yigitbasi O,Ozturk U,Goktug HN,et al.Prognostic factors in metastatic prostate cancer.Urol Oncol,2009.[Epub ahead of Print].
  • 10Kwak C,Jeong SJ,Park MS,et al.Prongostic singnifcance of the nadir prostate specific antigen level after hormnone therapy for prostate cancer.J Urol,2002,168(3):995-1000.

共引文献359

同被引文献28

引证文献3

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部